Our impact

Professor Hans Clevers
Multiple cancers
Mini tumour organoids to help personalise cancer treatment

You helped fund research that allowed scientists to grow mini tumour organoids in the lab from a patient’s own cancer cells to study the disease and personalise treatment.

Mark Cragg In Lab
Blood cancer
Helping to develop new blood cancer drugs

Your support helped Professor Mark Cragg discover how drugs could be used to target and destroy cancer cells and helped develop new blood cancer treatments.

Dr Awen Gallimore
Bowel cancer
Clinical trials to stop bowel cancer coming back

Your support in 2005 has helped launch clinical trials testing a promising new treatment option for people with bowel cancer. 

General cancer research
Making the most of your donations to start new cures

How do we know that what we are doing works? We explore the average return on investment of our research funding. 

John Maher Groupshot
Head & neck cancer
Developing a new type of cancer immunotherapy

With your support Dr John Maher's impact on cancer research has led to the development of a brand new type of immunotherapy that is now in clinical trials. 

Louis Vermeulen
Bowel cancer
Using lithium to prevent bowel cancer

Your support helped Professor Louis Vermeulen make a discovery that has led to the psychiatric drug lithium being tested in clinical trials to prevent bowel cancer.

Donate today to start new cures

Be part of the united effort to stop lives being cut short by cancer.

The latest discoveries from our labs:

Multiple cancers
Our top cancer research breakthroughs of 2025

Explore the most exciting new cancer breakthroughs of 2025. Discover the latest research on cancer, new treatments, and how you are helping our scientists get closer to new cures.

Breast cancer
New and recent breast cancer breakthroughs

Our research is finding new cures for breast cancer. Find out what new breakthroughs have happened recently in breast cancer research.

Breast cancer
Potential new way to predict breast cancer return after radiotherapy

Thanks to the support of our Curestarters, a team of researchers has identified a molecular signal that could help predict whether early-stage breast cancer might return after radiotherapy.

Become a Curestarter with just one click.

Sign up to receive our monthly newsletter, jam-packed with answers to your cancer research questions, updates on our latest news and breakthroughs, and opportunities to support our pioneering research. 

Sign up today

For information about how we use your personal data please view our privacy policy